• Increased Risk Of Narcolepsy In Young Adults Linked To Swine Flu Vaccination

    By -

    Pandemrix is an influenza vaccination, created in 2009 to combat H1N1, known as Swine Flu. Now, a team of clinicians testing the vaccine for links to immune-related or neurological diseases have linked Pandemrix to an increased risk of narcolepsy in young adults.

    Children and the elderly are strongly advised by health officials to get the anti-swine flu vaccine due to their susceptibility for developing flu-related complications. Typically, H1N1 vaccinations such as Pandemrix are designed to do more good than harm by providing protection against certain strains of the virus. However, a recent study, published in the Journal of Internal Medicine, has found Pandemrix increases the risk of neurological and immune-related diseases like narcolepsy in children and adolescents.

    Using a population-based prospective cohort study, the team analyzed data from regional vaccination registries and national health registries, covering seven healthcare regions and 61% of the Swedish population.

    While the team did not identify any link to a large number of immune-related or neurological diseases, they did confirm an increased risk in diagnosis of narcolepsy in individuals younger than 20 years of age, and observed a trend towards an increased risk amongst young adults between 21 and 30.

    “The follow-up of Pandemrix vaccinations in a large registry based study in Sweden confirms an increased risk of narcolepsy in children and adolescents, while also providing reassuring results for a large number of other neurological and immune related diseases,” said Dr. I. Persson from the Karolinska Institutet, Stockholm.

    The adverse effect of narcolepsy from Pandemrix vaccination may be a vital issue for those who are getting flu vaccines in other countries, such as Northern Europe, or if someone has imported a flu vaccine from another country and used it without permission in the U.S. Common side effects with Pandemrix are headache, arthralgia (joint pain), myalgia (muscle pain), swelling and pain at the site of the injection, shivering, increased sweating, and fatigue, according to the European Medicines Agency.
    Please Read this Article at



    Leave a Reply

    Your email address will not be published. Required fields are marked *